Cargando…

Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus

ABSTRACT: Nucleoprotein (NP) functions crucially in the replicative cycle of influenza A virus (IAV) via forming the ribonucleoprotein complex together with PB2, PB1, and PA proteins. As its high conservation, NP ranks one of the hot targets for design of universal diagnostic reagents and antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Min, Jiao, Jun, Liu, Suhan, Zhao, Wanchen, Ge, Zhichuang, Cai, Kairui, Xu, Lijun, He, Dongchang, Zhang, Xinyu, Qi, Xian, Jiang, Wenming, Zhang, Pinghu, Wang, Xiaoquan, Hu, Shunlin, Liu, Xiufan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947902/
https://www.ncbi.nlm.nih.gov/pubmed/36820898
http://dx.doi.org/10.1007/s00253-023-12433-3
_version_ 1784892662148497408
author Gu, Min
Jiao, Jun
Liu, Suhan
Zhao, Wanchen
Ge, Zhichuang
Cai, Kairui
Xu, Lijun
He, Dongchang
Zhang, Xinyu
Qi, Xian
Jiang, Wenming
Zhang, Pinghu
Wang, Xiaoquan
Hu, Shunlin
Liu, Xiufan
author_facet Gu, Min
Jiao, Jun
Liu, Suhan
Zhao, Wanchen
Ge, Zhichuang
Cai, Kairui
Xu, Lijun
He, Dongchang
Zhang, Xinyu
Qi, Xian
Jiang, Wenming
Zhang, Pinghu
Wang, Xiaoquan
Hu, Shunlin
Liu, Xiufan
author_sort Gu, Min
collection PubMed
description ABSTRACT: Nucleoprotein (NP) functions crucially in the replicative cycle of influenza A virus (IAV) via forming the ribonucleoprotein complex together with PB2, PB1, and PA proteins. As its high conservation, NP ranks one of the hot targets for design of universal diagnostic reagents and antiviral drugs for IAV. Here, we report an anti-NP murine monoclonal antibody (mAb) 5F10 prepared from traditional lymphocyte hybridoma technique with the immunogen of a clade 2.3.4.4 H5N1 subtype avian influenza virus. The specificity of mAb 5F10 to NP protein was confirmed by immunofluorescence assay and western blotting, and the mAb 5F10 could be used in immunoprecipitation and immunohistochemistry assays. Importantly, mAb 5F10 possessed broad-spectrum reactivity against H1~H11 subtypes of avian influenza viruses, including various HA clades of H5Nx subtype. In addition, mAb 5F10 also showed good affinity with H1N1 and H3N2 subtype influenza viruses of swine and human origin. Furthermore, the recognized antigenic epitope of mAb 5F10 was identified to consist of the conserved amino acid motif (81)EHPSA(85) in the second flexible loop region of NP protein through screening the phage display peptide library. Collectively, the mAb 5F10 which recognizes the novel universal NP linear B-cell epitope of IAV with diverse origins and subtypes will be a powerful tool for NP protein-based structural, functional, and mechanistic studies, as well as the development of detection methods and universal vaccines for IAV. KEY POINTS: • A broad-spectrum mAb against various subtypes and sources of IAV was developed • The mAb possessed good reactivity in IFA, western blot, IP, and IHC assays • The mAb targeted a novel conserved linear B-cell epitope involving (81)EHPSA(85) on NP protein
format Online
Article
Text
id pubmed-9947902
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99479022023-02-23 Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus Gu, Min Jiao, Jun Liu, Suhan Zhao, Wanchen Ge, Zhichuang Cai, Kairui Xu, Lijun He, Dongchang Zhang, Xinyu Qi, Xian Jiang, Wenming Zhang, Pinghu Wang, Xiaoquan Hu, Shunlin Liu, Xiufan Appl Microbiol Biotechnol Applied Genetics and Molecular Biotechnology ABSTRACT: Nucleoprotein (NP) functions crucially in the replicative cycle of influenza A virus (IAV) via forming the ribonucleoprotein complex together with PB2, PB1, and PA proteins. As its high conservation, NP ranks one of the hot targets for design of universal diagnostic reagents and antiviral drugs for IAV. Here, we report an anti-NP murine monoclonal antibody (mAb) 5F10 prepared from traditional lymphocyte hybridoma technique with the immunogen of a clade 2.3.4.4 H5N1 subtype avian influenza virus. The specificity of mAb 5F10 to NP protein was confirmed by immunofluorescence assay and western blotting, and the mAb 5F10 could be used in immunoprecipitation and immunohistochemistry assays. Importantly, mAb 5F10 possessed broad-spectrum reactivity against H1~H11 subtypes of avian influenza viruses, including various HA clades of H5Nx subtype. In addition, mAb 5F10 also showed good affinity with H1N1 and H3N2 subtype influenza viruses of swine and human origin. Furthermore, the recognized antigenic epitope of mAb 5F10 was identified to consist of the conserved amino acid motif (81)EHPSA(85) in the second flexible loop region of NP protein through screening the phage display peptide library. Collectively, the mAb 5F10 which recognizes the novel universal NP linear B-cell epitope of IAV with diverse origins and subtypes will be a powerful tool for NP protein-based structural, functional, and mechanistic studies, as well as the development of detection methods and universal vaccines for IAV. KEY POINTS: • A broad-spectrum mAb against various subtypes and sources of IAV was developed • The mAb possessed good reactivity in IFA, western blot, IP, and IHC assays • The mAb targeted a novel conserved linear B-cell epitope involving (81)EHPSA(85) on NP protein Springer Berlin Heidelberg 2023-02-23 2023 /pmc/articles/PMC9947902/ /pubmed/36820898 http://dx.doi.org/10.1007/s00253-023-12433-3 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Applied Genetics and Molecular Biotechnology
Gu, Min
Jiao, Jun
Liu, Suhan
Zhao, Wanchen
Ge, Zhichuang
Cai, Kairui
Xu, Lijun
He, Dongchang
Zhang, Xinyu
Qi, Xian
Jiang, Wenming
Zhang, Pinghu
Wang, Xiaoquan
Hu, Shunlin
Liu, Xiufan
Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus
title Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus
title_full Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus
title_fullStr Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus
title_full_unstemmed Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus
title_short Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus
title_sort monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza a virus
topic Applied Genetics and Molecular Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947902/
https://www.ncbi.nlm.nih.gov/pubmed/36820898
http://dx.doi.org/10.1007/s00253-023-12433-3
work_keys_str_mv AT gumin monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT jiaojun monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT liusuhan monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT zhaowanchen monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT gezhichuang monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT caikairui monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT xulijun monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT hedongchang monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT zhangxinyu monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT qixian monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT jiangwenming monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT zhangpinghu monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT wangxiaoquan monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT hushunlin monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus
AT liuxiufan monoclonalantibodytargetinganovellinearepitopeonnucleoproteinconferspanreactivitytoinfluenzaavirus